Polen Capital Abbott Laboratories Transaction History

Polen Capital Management LLC

$30.8 Billion
Q3 2025

A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Abbott Laboratories stock. As of the latest transaction made, Polen Capital Management LLC holds 7,420,604 shares of ABT stock, worth $965 Million. This represents 3.23% of its overall portfolio holdings.

Number of Shares

7,420,604

Previous 10,669,498 30.45%

Holding current value

$965 Million

Previous $1.45 Billion 31.51%

% of portfolio

3.23%

Previous 4.46%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$120.51 - $136.62 $392 Million - $444 Million	-3,248,894 Reduced 30.45%	7,420,604 $994 Million
Q2 2025 Aug 13, 2025	SELL	$123.95 - $138.08 $88.8 Million - $98.9 Million	-716,079 Reduced 6.29%	10,669,498 $1.45 Billion
Q1 2025 May 12, 2025	SELL	$111.1 - $140.22 $145 Million - $183 Million	-1,302,786 Reduced 10.27%	11,385,577 $1.51 Billion
Q4 2024 Feb 10, 2025	SELL	$111.93 - $119.39 $140 Million - $149 Million	-1,249,247 Reduced 8.96%	12,688,363 $1.44 Billion
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $137 Million - $162 Million	-1,368,212 Reduced 8.94%	13,937,610 $1.59 Billion

Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $84.2 Million - $93.9 Million	-835,415 Reduced 5.18%	15,305,822 $1.59 Billion
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $291 Million - $321 Million	2,652,929 Added 19.67%	16,141,237 $1.83 Billion
Q4 2023 May 10, 2024	BUY	$90.19 - $110.4 $131,677 - $161,184	1,460 Added 0.01%	13,488,308 $1.48 Billion
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $551,241 - $674,764	6,112 Added 0.05%	13,486,848 $1.48 Billion
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $36.4 Million - $43.7 Million	-381,118 Reduced 2.75%	13,480,736 $1.31 Billion
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $39.1 Million - $43.5 Million	-387,593 Reduced 2.72%	13,861,854 $1.51 Billion
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $35.8 Million - $42.1 Million	-369,295 Reduced 2.53%	14,249,447 $1.44 Billion
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $102 Million - $119 Million	-1,070,770 Reduced 6.82%	14,618,742 $1.61 Billion
Q3 2022 Nov 04, 2022	BUY	$96.76 - $112.03 $30.6 Million - $35.4 Million	316,416 Added 2.06%	15,689,512 $1.52 Billion
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $720 Million - $870 Million	-7,050,232 Reduced 31.44%	15,373,096 $1.67 Billion
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $14.6 Million - $17.8 Million	-128,030 Reduced 0.57%	22,423,328 $2.65 Billion
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $62.2 Million - $76.2 Million	538,662 Added 2.45%	22,551,358 $3.17 Billion
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $3.23 Million - $3.57 Million	27,692 Added 0.13%	22,012,696 $2.6 Billion
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $135 Million - $158 Million	1,272,680 Added 6.14%	21,985,004 $2.55 Billion
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $24 Million - $28.2 Million	220,118 Added 1.07%	20,712,324 $2.48 Billion
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $114 Million - $124 Million	1,087,508 Added 5.6%	20,492,206 $2.24 Billion
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $63.5 Million - $77.1 Million	692,903 Added 3.7%	19,404,698 $2.11 Billion
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $157 Million - $201 Million	2,052,212 Added 12.32%	18,711,795 $1.71 Billion
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $486 Million - $711 Million	7,735,426 Added 86.68%	16,659,583 $1.31 Billion
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $691 Million - $769 Million	8,802,518 Added 7236.59%	8,924,157 $775 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $9.95 Million - $10.8 Million	121,639 New	121,639 $10.2 Million

Others Institutions Holding ABT

# of Institutions

3,653

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track Polen Capital's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polen Capital Management LLC and Polen Capital with notifications on news.

Account